We next examined the dynamics and expression of ACE2me and ACE2 in peripheral blood mononuclear cells (PBMCs) isolated from COVID-19 patients after further optimization and validation of ACE2me immunofluorescence staining in PMBCs (Supplementary Fig. 7a–c). The gene discussed is ACE2; the disease is COVID-19.